文献速递细菌感染、耐药与抗菌药物

达托霉素联合苯唑西林或头孢洛林对成骨细胞内MSSA和MRSA的活性

Intraosteoblastic activity of daptomycin in combination with oxacillin and ceftaroline against MSSA and MRSA.
PubMed 文献 · J Antimicrob Chemother · 2017-01-01

本研究在离体成骨细胞感染模型中评估达托霉素联合苯唑西林或头孢洛林对MSSA和MRSA的胞内活性。达托霉素单药对胞内MSSA无效、对MRSA弱效;达托霉素联合苯唑西林显著优于单药,而联合头孢洛林未优于头孢洛林单药。酸性条件下苯唑西林对MRSA的MIC从>256降至0.023 mg/L,棋盘法显示与达托霉素 additive 效应。

要点

  • 达托霉素单药对成骨细胞内MSSA无效,对MRSA仅弱效。
  • 达托霉素联合苯唑西林对胞内MSSA和MRSA均显著优于单药。
  • 达托霉素联合头孢洛林未优于头孢洛林单药。

核心结论

  • 在酸性胞内条件下,苯唑西林增强达托霉素对金黄色葡萄球菌(包括MRSA)成骨细胞内储库的活性。

研究设计与样本

  • 离体成骨细胞感染模型,分别感染MRSA菌株或其同源MSSA菌株,用常规骨内治疗浓度孵育24小时。
  • 采用棋盘法在pH 5(模拟溶酶体条件)下测定MSSA和MRSA的MIC。

主要发现

  • 达托霉素未减少胞内MSSA接种量,对MRSA与未处理细胞相比弱效(-27.6%;P < 10-3)。
  • 苯唑西林和头孢洛林显示显著胞内活性,包括苯唑西林对MRSA感染细胞(-43.2%;P < 10-3)。
  • 达托霉素/苯唑西林联合对胞内MSSA和MRSA的活性显著高于达托霉素和苯唑西林单药(分别-44.4%和-57.2%;P < 0.05)。
  • 达托霉素/头孢洛林联合未比头孢洛林单药更有效。
  • pH从7降至5时,苯唑西林对MRSA的MIC从>256降至0.023 mg/L,棋盘法显示pH 5下达托霉素/苯唑西林对MRSA呈相加效应。

关键数值与推荐

  • 苯唑西林对MRSA的MIC在pH 7时为>256 mg/L,pH 5时为0.023 mg/L。
  • 达托霉素/苯唑西林联合对胞内MSSA和MRSA的降低比例分别为-44.4%和-57.2%(P < 0.05)。

临床怎么用

  • 对于骨与关节感染中金黄色葡萄球菌胞内储库,可考虑达托霉素联合苯唑西林以增强胞内清除,尤其针对MRSA。
  • 达托霉素联合头孢洛林未见额外胞内获益,不宜以此组合作为增强胞内活性的策略。

局限性

  • 研究为离体成骨细胞感染模型,结果需临床研究验证。
  • 仅测试特定MRSA菌株及其同源MSSA菌株,代表性有限。
  • 未评估其他β-内酰胺或联合方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Staphylococcus aureus intracellular reservoir is associated with bone and joint infection (BJI) chronicity. As daptomycin is increasingly prescribed in BJI, strategies for improving its reduced intracellular activity should be promoted. OBJECTIVES: Based on the known in vitro synergy of daptomycin with β-lactams, the aim of the present study was to evaluate the intracellular activity of these combinations in an ex vivo osteoblast infection model. METHODS: Osteoblastic cells infected with an MRSA strain or its isogenic MSSA counterpart were incubated for 24 h with daptomycin, oxacillin or ceftaroline alone or in combination using usual intraosseous therapeutic concentrations. Intracellular bacteria were quantified by plating cell lysates. MICs for MSSA and MRSA were determined using the chequerboard method at pH 5 to mimic conditions expected within lysosomes, the foremost S. aureus intracellular location. RESULTS: Daptomycin failed to reduce the intracellular MSSA inoculum, and was weakly active against MRSA compared with untreated cells (-27.6%; P < 10-3). Oxacillin and ceftaroline revealed significant intracellular activity, including oxacillin against MRSA-infected cells (-43.2%; P < 10-3). The daptomycin/oxacillin combination was significantly more active against intracellular MSSA and MRSA compared with daptomycin and oxacillin alone (-44.4% and -57.2%, respectively; P < 0.05). In contrast, daptomycin/ceftaroline was not more efficient than ceftaroline alone. Interestingly, oxacillin MICs for MRSA decreased in vitro from >256 to 0.023 mg/L when the pH decreased from 7 to 5, and chequerboards showed an additive effect of the daptomycin/oxacillin combination against MRSA at pH 5. CONCLUSIONS: In acidic intracellular conditions, oxacillin enhances daptomycin activity against the intraosteoblastic reservoir of S. aureus, including MRSA.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Dupieux C, Trouillet-Assant S, Camus C, et al. Intraosteoblastic activity of daptomycin in combination with oxacillin and ceftaroline against MSSA and MRSA. J Antimicrob Chemother. 2017. PMID: 28961767. doi:10.1093/jac/dkx314

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。